medline.ch Urologie-Nephrologie

	Is This the End of the Cisplatin Eligibility Era in Muscle-invasive Bladder Cancer? Letter in reference to: Matthew D. Galsky, BegoÃ±a P. Valderrama, Marco Maruzzo, et al. Enfortumab vedotin and pembrolizumab in cisplatin-eligible bladder cancer. N Engl J Med 2026;395:338-48. doi:10.1056/NEJMoa2601486; and Galsky MD, Hahn NM, Rosenberg J, et al. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. Lancet Oncol 2011;12:211-214. doi:10.1016/S1470-2045(10)70275-8. Eur Urol Giannatempo P, Cerbone L, Calabrò F. PMID: 42760245 [PubMed - as supplied by publisher]
	Safety of short-term non-steroidal anti-inflammatory drug use in the postoperative setting in paediatric patients with chronic kidney disease: protocol for a randomised, placebo-controlled trial. BMJ Open Xiang AH, Hwang CK, Clennon E, To T, Pyrzanowski J, Calderon AB, Wilson S, Shields E, Beltran G, Sevick C, Bock M, Harris KT, Rove KO. PMID: 42760073 [PubMed - indexed for MEDLINE]
	Can early (68)Ga-PSMA-11 PET/CT predict 6-month disease control in patients receiving first-line systemic therapy for metastatic clear-cell renal cell carcinoma? Protocol for the multicentre prospective phase II PSMA-RENAL study in Belgium. BMJ Open Seront E, Lhommel R, Van Maanen A, Pasoglou V, Gizzi M, Grisay G, Tombal B. PMID: 42760067 [PubMed - indexed for MEDLINE]
	The PART randomised trial protocol: Partial Ablation versus Radical Treatment for prostate cancer. BJU Int Bryant RJ, Leslie T, Laniado M, Sharma A, Grey A, Withington J, Blick C, Streeter E, Kotwal S, Hulson O, Cross W, Good DW, Omer A, Shah TT, Bedi N, Stroman L, Moore C, Sooriakumaran P, Ahmed HU, Brewster SF, Barber VS, Hewitt A, Calvert C, Scaife J, Shepherd D, Landeiro F, Wolstenholme J, Camilleri P, Verrill C, Lovell S, Pirkl M, Gleeson F, Williams R, Cook J, Holt CR, Hill M, Cook J, Radford J, Marian IR, Macpherson R, Elliott D, Donovan JL, Hamdy FC. PMID: 42760023 [PubMed - as supplied by publisher]
	Comprehensive geriatric assessment for older people living with chronic kidney disease and frailty: time to set a new goal? Kidney Int Nixon AC. PMID: 42760022 [PubMed - indexed for MEDLINE]
	Somatostatin analogues for ADPKD: ending the confusing story of mGFR and eGFR. Kidney Int Gansevoort RT, Bais T. PMID: 42760021 [PubMed - indexed for MEDLINE]
	Frailty in children with chronic kidney disease and kidney failure. Kidney Int Chan EY, Cara-Fuentes G. PMID: 42760017 [PubMed - indexed for MEDLINE]
	Authors' response to "Is a 4% genetic diagnostic yield in living kidney donors truly negligible?". Kidney Int Schott C, Arnaldi M, Connaughton DM. PMID: 42760004 [PubMed - in process]
	Is a 4% genetic diagnostic yield in living kidney donors truly negligible? Kidney Int Tang G, Sun M, Zhao H. PMID: 42760003 [PubMed - in process]
	Survival benefit of deceased donor kidney transplantation versus continued dialysis: international target trial emulation. BMJ Hellemans R, Chesnaye NC, Kramer A, Fu EL, Arnol M, Åsberg A, Bistrup C, Ferraro PM, Heldal K, Helve J, Legeai C, Medcalf J, Nitsch D, Oliveras L, Pérez-Sáez MJ, Ponte B, Savoye E, Segelmark M, Shanmugaranjan S, Sørensen SS, Torra R, Ortiz A, Jager KJ, Stel VS. PMID: 42759976 [PubMed - indexed for MEDLINE]
	From quality indicator to quality measurement: design and implementation of an automated audit and feedback tool for chronic kidney disease in Belgian primary care. BMJ Health Care Inform Soetaert J, Paredis L, Vaes B, Van den Wyngaert I, Van Pottelbergh G, Van den Bulck S. PMID: 42759973 [PubMed - indexed for MEDLINE]
	Leveraging time-series electronic health records with large language models for chronic kidney disease diagnosis in primary care. BMJ Health Care Inform Wu J, Zheng Y, He Z, Zuo Q, Zhang W, Li P, Luxia Z. PMID: 42759972 [PubMed - indexed for MEDLINE]
	Circadian clock-driven inter-organ crosstalk in cardiovascular-kidney-metabolic (CKM) syndrome: Molecular mechanisms, pathological progression, and chronotherapeutic strategies. Metabolism Cai Y, Qin Y, Zhu M, Cheng X, Liu Y, Liu Y. PMID: 42759925 [PubMed - as supplied by publisher]
	Plasma cfDNA fragmentomics enables non-invasive detection and preoperative risk stratification of bladder cancer in a multicenter study. Cancer Lett Liu K, Bao H, Li G, Ran W, Yang P, Zhang Z, Li W, Li N, Ren M, Ding T, He P, Yang S, Hong X, Wang K, Xing X. PMID: 42759922 [PubMed - as supplied by publisher]
	Development and Internal Validation of a Nomogram for Delayed Treatment in Pediatric Testicular Torsion: A Retrospective Study Spanning Over Two Decades. J Pediatr Surg Sun M, Yu C, Ji F, Zeng Z, Song Y, Liu Y, Wang R, Hong Y, Wu S. PMID: 42759839 [PubMed - as supplied by publisher]
	Trends in the utilization of minimally invasive therapies for overactive bladder among older adults: a national Medicare study. Urology Crow A, Wang L, Shatkin-Margolis A, Nseyo U, Zuo SW, Boscardin WJ, Covinsky K, Suskind AM. PMID: 42759772 [PubMed - as supplied by publisher]
	Immunometabolic Regulation of Macrophage Function in Cardio-Hepatic-Renal Comorbidities: Mechanisms and Therapeutic Opportunities. Mol Cell Endocrinol Bai X, Bai J, Zhou Y. PMID: 42759644 [PubMed - as supplied by publisher]
	Healthy Lifestyle, Genetic Susceptibility and Risk of Kidney Stone Disease in the UK Biobank: A Prospective Cohort Study. Mayo Clin Proc Xu K, Yao Z, Wang Y, Na L, Liu J, Xia Y, Jin X, Li Z, Liu Y, Bai S. PMID: 42759605 [PubMed - as supplied by publisher]
	Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study. Lancet Gastroenterol Hepatol Sanchez LO, Clària J, Galvanin C, Aguilar F, Layese R, Serra M, Jiménez-Gracia L, Nieto P, Castven D, Frankova S, Jirsa M, Tornai D, Curto-Vilalta A, Farias AQ, Papp M, Zitelli PM, Caraceni P, Zaccherini G, Goncalves LL, Alessandria C, Pereira G, Laleman W, Gadano AC, Piano S, Mattos AZ, Germanova D, Lucidi V, Soret D, Wandji LCN, Uschner FE, Torre A, Vargas V, Mendes LSC, Mookerjee RP, Benitez C, Alvares-da-Silva MR, Remmelink M, Bittencourt PL, Albillos A, Couto CA, Bañares R, Mendizabal M, Degré D, Toledo CL, Janicko M, Mazo DF, Barradas MC, Bernal W, Miranda AZL, Padilla-Machaca PM, Zipprich A, Malé-Velázquez R, Moreno C, Lyra AC, Carrilho F, Fernandez J, Trebicka J, Jalan R, Angeli P, Stefanescu H, Rautou PE, Buch S, Louvet A, Marquardt JU, Gustot T, Heyn H, Nieto JC, Arroyo V, Ganne-Carrié N, Sperl J, Moreau R, Mathurin P, Nahon P, Trépo E, CANONIC, PREDICT, ACLARA, ANRS CO12 CirVir, and CIRRAL study groups. PMID: 42759531 [PubMed - as supplied by publisher]
	Feasibility of prostate offline adaptive radiation therapy using iterative reconstructed CBCT to optimize the ART workflow. Phys Med Vicedo González MA, García Hernández MT, Alcaraz Lozano ML, Pardos RG, Rovira Escutia JJ, Meseguer DP, Cabañero DG, Gilabert JB, García-Mollá R. PMID: 42759430 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 481358

Seite 1 von 24068

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung